Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published online in The Lancet Infectious Diseases.
The results are significant as public health experts have long warned that the parasite responsible for most malaria cases, Plasmodium falciparum, is developing resistance to widely used treatments. New medications are needed to build up secondary defenses against drug-resistant strains of the parasite.
The drug, called AQ-13, was able to clear the parasite responsible for the disease within a week, matching the effectiveness of the most widely used treatment regimen.
“The potential long-term implications are bigger than one drug. The conceptual step here is that if you understand the resistance well enough, you may be actually be able to develop others as well.”
Dr. Donald Krogstad
“The clinical trial results are extraordinarily encouraging,” said Dr. Donald Krogstad, senior author and professor of tropical medicine at Tulane University School of Public Health and Tropical Medicine. “Compared to the current first-line recommendation for treatment of malaria, the new drug comes out very well.”
Mosquitoes infected by a parasite spread malaria, causing more than 200 million illnesses across the globe and more than 400,000 deaths annually. For decades, chloroquine was used to treat malaria until Plasmodium falciparum developed resistance. Now, a drug combination — artemether and lumefantrine — is the primary treatment for malaria although resistance is also developing to the drug combination in some countries.
Researchers recruited 66 adult men in Mali with uncomplicated malaria, which is defined as malaria that isn’t life threatening. Half were treated with AQ-13 and the other half received artemether and lumefantrine. Both drug groups had similar cure rates. However, five participants in AQ-13 group left the study or were lost to follow-up and two participants in the artemether/lumefantrine group had late treatment failures with recurrence of their original infections.
Researchers hope to expand testing of the drug to more participants, including women and children, before it can be widely recommended as a new treatment. Krogstad said that the same biotechnology that helped the team develop the new drug has also identified similar drugs that also hold promise against drug-resistant parasites.
The Latest on: Malaria
- 3 dead, 404 dengue and malaria cases detected in Dakshina Kannadaon July 21, 2019 at 5:17 am
‘In last 3 weeks, there is spike in number of patients admitted to hospitals due to viral fever,’ Dy Commissioner Sasikanth Senthil said. Senthil said the district administration and health department ... […]
- Africa: Malaria Vaccine Not Just a Dream - Dr. Aminatou Koneon July 19, 2019 at 5:51 pm
Dakar — An African scientific conference this week was "a platform for this young generation to express their views about how they perceive the future of science in Africa. We will leave here ... […]
- Support for Global Fund imperative as U.S. tries to save lives from TB, malaria, AIDSon July 17, 2019 at 3:10 pm
Before I was pastor of The Cornerstone Church, I spent a year with at-risk kids in Thailand. There, I witnessed the systemic impacts of poverty. My faith calls me to uplift the vulnerable, in Boise ... […]
- Bull market malaria and other advisory firm ailmentson July 17, 2019 at 8:40 am
The stock market's historic bull run is masking the impact of industry disruptions. Take a moment to check whether your organization is vulnerable to any of the following conditions. Bull market ... […]
- Avian malaria may explain decline of London's house sparrowon July 17, 2019 at 7:44 am
July 17 (UPI) --Since 1995, London's iconic house sparrow population has declined 71 percent. New research suggests avian malaria is the primary driver of the population decline. New tests showed ... […]
- New Tool Finds Bed Net Use Spotty, Raising Malaria Riskon July 16, 2019 at 2:03 pm
A new tool for monitoring bed net use reveals that people don’t use their bed nets consistently, which could contribute to the recent slowdown in progress in the fight against malaria. More than ... […]
- Analysis-ready datasets for insecticide resistance phenotype and genotype frequency in African malaria vectorson July 15, 2019 at 2:15 am
Current malaria control activities are heavily reliant on vector control using insecticides, which means resistance to these compounds has the potential to derail control efforts 1,2. Studies have ... […]
- Mosquito surveillance in Madagascar reveals new insight into malaria transmissionon July 11, 2019 at 9:48 pm
The Ministry of Public Health in Madagascar has reported thousands of malaria cases over the past months. In March, more than 600 cases of malaria were reported weekly and at least 2,000 cases have ... […]
- Malaria Immune Protection in Mosquitoes Is a Study in Dualityon July 11, 2019 at 5:17 am
To understand parasitism, one needs to comprehend the often dual nature of many parasitic organisms. For instance, the malaria parasite (Plasmodium) has a two-stage lifecycle where it interacts with ... […]
- How the mosquito immune system fights off the malaria parasiteon July 10, 2019 at 9:57 am
A new study from Iowa State University entomologists describes how mosquitoes fight off parasites that cause malaria, a disease that sickens millions of people every year. Roughly 219 million ... […]
via Google News and Bing News